Literature DB >> 23903876

Tertiary structural elements determine the extent and specificity of messenger RNA editing.

Leila E Rieder1, Cynthia J Staber, Barry Hoopengardner, Robert A Reenan.   

Abstract

The specificity and extent of RNA editing by ADAR enzymes is determined largely by local primary sequence and secondary structural imperfections in duplex RNA. Here we surgically alter conserved cis elements associated with a cluster of ADAR modification sites within the endogenous Drosophila paralytic transcript. In addition to the local requirement for a central imperfect RNA duplex containing the modified adenosines, we demonstrate that a secondary RNA duplex containing splicing signals strongly modulates RNA editing. A subtle non-coding mutation, extending base pairing of this accessory helix, confers significant phenotypic consequences via effects on splicing. Through mutation/counter-mutation, we also uncover and functionally replace a highly conserved intronic long-range tertiary pseudoknot that is absolutely required for deamination of one particular adenosine in the central duplex. Our results demonstrate that complex RNA tertiary structures, which may be difficult to predict computationally, form in vivo and can regulate RNA-editing events.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23903876     DOI: 10.1038/ncomms3232

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  21 in total

1.  Human coding RNA editing is generally nonadaptive.

Authors:  Guixia Xu; Jianzhi Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-24       Impact factor: 11.205

2.  Noncoding regions of C. elegans mRNA undergo selective adenosine to inosine deamination and contain a small number of editing sites per transcript.

Authors:  Emily C Wheeler; Michael C Washburn; Francois Major; Douglas B Rusch; Heather A Hundley
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

Review 3.  A-to-I RNA editing - immune protector and transcriptome diversifier.

Authors:  Eli Eisenberg; Erez Y Levanon
Journal:  Nat Rev Genet       Date:  2018-08       Impact factor: 53.242

4.  Cis regulatory effects on A-to-I RNA editing in related Drosophila species.

Authors:  Anne L Sapiro; Patricia Deng; Rui Zhang; Jin Billy Li
Journal:  Cell Rep       Date:  2015-04-23       Impact factor: 9.423

Review 5.  RNA Structures as Mediators of Neurological Diseases and as Drug Targets.

Authors:  Viachaslau Bernat; Matthew D Disney
Journal:  Neuron       Date:  2015-07-01       Impact factor: 17.173

6.  Adenosine Deaminase That Acts on RNA 3 (ADAR3) Binding to Glutamate Receptor Subunit B Pre-mRNA Inhibits RNA Editing in Glioblastoma.

Authors:  Eimile Oakes; Ashley Anderson; Aaron Cohen-Gadol; Heather A Hundley
Journal:  J Biol Chem       Date:  2017-02-06       Impact factor: 5.157

7.  Genome wide analyses uncover allele-specific RNA editing in human and mouse.

Authors:  Zhong-Yin Zhou; Yue Hu; Aimin Li; Ying-Ju Li; Hui Zhao; Si-Qi Wang; Newton O Otecko; Dejiu Zhang; Jin-Huan Wang; Yajun Liu; David M Irwin; Yan Qin; Ya-Ping Zhang
Journal:  Nucleic Acids Res       Date:  2018-09-28       Impact factor: 16.971

8.  Molecular biology of insect sodium channels and pyrethroid resistance.

Authors:  Ke Dong; Yuzhe Du; Frank Rinkevich; Yoshiko Nomura; Peng Xu; Lingxin Wang; Kristopher Silver; Boris S Zhorov
Journal:  Insect Biochem Mol Biol       Date:  2014-04-03       Impact factor: 4.714

9.  Trade-off between Transcriptome Plasticity and Genome Evolution in Cephalopods.

Authors:  Noa Liscovitch-Brauer; Shahar Alon; Hagit T Porath; Boaz Elstein; Ron Unger; Tamar Ziv; Arie Admon; Erez Y Levanon; Joshua J C Rosenthal; Eli Eisenberg
Journal:  Cell       Date:  2017-04-06       Impact factor: 41.582

Review 10.  Recent developments in the characterization of nucleic acids by liquid chromatography, capillary electrophoresis, ion mobility, and mass spectrometry (2010-2020).

Authors:  Inês C Santos; Jennifer S Brodbelt
Journal:  J Sep Sci       Date:  2020-10-15       Impact factor: 3.645

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.